Delivery Order SPE2DB20D1100-SPE2DB24FC3Q2

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $1,580.64, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on a firm fixed-price basis. This delivery order contract has a completion date of June 6, 2024 and does not utilize any set-aside designations....
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,053.76, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This is a delivery order contract with a firm fixed price, and the ultimate completion date is May 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $8,367.60, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $1,053.76 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 23, 2024, with a completion date of May 24, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. The contract, valued at $1,958.03, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) on behalf of the Department of Defense (DoD). The contract, valued at $1,053.76, was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,604.16, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $7,806.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,768.26, is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 through November 2026. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with no set-aside designation. Amerisourcebergen...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,621.85 firm-fixed-price delivery order is for ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This contract is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables efficient government procurement...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC3Q2
    Delivery Order

This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,375.02, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award appears to be a delivery order issued under this broader IDC. The contract is a Firm Fixed Price Delivery Order with no set-aside designation.

Generated 9/19/24, 9:48 AM